Plunkett Research Online: Immunovaccine Inc.

IMMUNOVACCINE INC. (IMV:TSE) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Immunovaccine Inc., is a biotechnology company. The company develops clinical stage human health vaccines......



Immunovaccine Inc.
Ticker: IMV
Exchange: TSE
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 902 492-1819
Fax: 902 492-0888
Address: 1344 Summer Street
Suite 412
Halifax, NS B3H 0A8 Canada

Types Of Business
Industry Ranks

Industry NAICS code:

Vaccines
ContactsDescription
Pierre LabbeCFO
Andrew J. SheldonChairman of the Board/Director
See More
Immunovaccine Inc., is a biotechnology company. The company develops clinical stage human health vaccines......See More See More

Auditor: PricewaterhouseCoopers LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201720162015201420132012
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: